Walleye Capital LLC Novo Cure LTD Transaction History

Walleye Capital LLC

$46.2 Billion
Q3 2024

A detailed history of Walleye Capital LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Walleye Capital LLC holds 8,000 shares of NVCR stock, worth $141,840. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,000

Previous 2,100 280.95%

Holding current value

$141,840

Previous $35,000 257.14%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.61 - $23.34 $129,266 - $193,278	-8,281 Reduced 81.2%	1,917 $29,000
Q2 2024 Aug 14, 2024	SELL	$11.83 - $24.05 $490,968 - $998,123	-41,502 Reduced 80.27%	10,198 $174,000
Q1 2024 May 15, 2024	SELL	$12.42 - $17.29 $749,956 - $1.04 Million	-60,383 Reduced 53.87%	51,700 $808,000
Q4 2023 Feb 14, 2024	SELL	$11.13 - $15.78 $262,267 - $371,839	-23,564 Reduced 17.37%	112,083 $1.67 Million
Q3 2023 Nov 14, 2023	BUY	$16.15 - $42.35 $1.54 Million - $4.05 Million	95,647 Added 239.12%	135,647 $2.19 Million
Q2 2023 Aug 14, 2023	BUY	$40.29 - $82.51 $1.61 Million - $3.3 Million	40,000 New	40,000 $1.66 Million
Q4 2022 Feb 14, 2023	BUY	$63.98 - $85.37 $467,565 - $623,883	7,308 New	7,308 $536,000
Q2 2022 Aug 08, 2022	BUY	$56.6 - $89.9 $168,215 - $267,182	2,972 New	2,972 $207,000
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $238,676 - $370,569	-2,128 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$58.05 - $111.31 $123,530 - $236,867	2,128 New	2,128 $237,000
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $560,333 - $769,535	-8,204 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $94,583 - $149,536	-1,529 Reduced 15.71%	8,204 $613,000
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $347,175 - $519,940	8,223 Added 544.57%	9,733 $615,000
Q1 2019 May 15, 2019	BUY	$31.96 - $56.12 $48,259 - $84,741	1,510 New	1,510 $73,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.86B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Account

Walleye Capital LLC Novo Cure LTD Transaction History